-
161
Efficacy of Intrathecal 0.75% Hyperbaric Ropivacaine versus 0.5% Hyperbaric Bupivacaine for Elective Inguinal and Perineal Surgery: A Randomised Double-blinded Clinical Study
Published 2025-02-01“…Materials and Methods: The present randomised double-blind clinical study, was carried out in the Department of Anaesthesia, Dr. …”
Get full text
Article -
162
-
163
Beneficial Effects of Ursodeoxycholic Acid on Metabolic Parameters and Oxidative Stress in Patients with Type 2 Diabetes Mellitus: A Randomized Double-Blind, Placebo-Controlled Clinical Study
Published 2024-01-01“…This prospective, double-blind, placebo-controlled clinical study included 60 patients with T2DM, randomly allocated to receive UDCA or placebo. …”
Get full text
Article -
164
-
165
-
166
-
167
Comparative Evaluation of Clinical and Radiographic Changes Following Delayed Implant Placement in Mandibular Posterior Region with or without i-PRF Activation: A Split Mouth Clinical Study
Published 2024-12-01“…Methods: A split-mouth clinical study design was used, involving ten participants with twenty sites of bilaterally missing mandibular molars. …”
Get full text
Article -
168
-
169
-
170
-
171
-
172
Accuracy of ESAT6-CFP10 skin test compared with tuberculin skin test in a healthy population: a randomized, blind, parallel controlled phase III clinical study
Published 2024-12-01“…Clinical trials Registration NCT02795260, Clinical Study of Recombinant Mycobacterium Tuberculosis Allergen ESAT6-CFP10 on Healthy People Aged 18–65(III-healthy), Registration Date: June 10, 2016.…”
Get full text
Article -
173
Diagnostics and Treatment of Peptic Ulcer in Adults (Clinical Guidelines of the Russian Gastroenterological Association, the Russian Society of Colorectal Surgeons, the Russian Endoscopic Society and the Scientific Society for the Clinical Study of Human Microbiome)
Published 2024-05-01Get full text
Article -
174
-
175
-
176
-
177
-
178
-
179
AOZORA: long-term safety and joint health in paediatric persons with haemophilia A without factor VIII inhibitors receiving emicizumab – protocol for a multicentre, open-label, phase IV clinical study
Published 2022-06-01“…The AOZORA study will evaluate the long-term safety and joint health of paediatric PwHA without factor (F)VIII inhibitors taking emicizumab; here, we report the details of the study protocol and baseline data.Methods and analysis AOZORA is a multicentre, open-label, phase IV clinical study in Japan that aims to enrol approximately 30 PwHA aged <12 years without FVIII inhibitors. …”
Get full text
Article -
180